Biomarkers in Atopic Dermatitis and Psoriasis The Netherlands
Completed
- Conditions
- 10014982Atopic dermatitisatopic eczema
- Registration Number
- NL-OMON48036
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
Patients with atopic dermatitis participating in the TREAT NL registry.
Patients can be part of the TREAT NL registry if they have atopic dermatitis
AND start with a systemic immunomodulating treatment or phototherapy in the
context op standard patient care
Exclusion Criteria
No participation in the TREAT NL registry, patients not recieving systemic
immunomodulating treatment or phototherapy as treatment for their eczema
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The combined efforts of BIOMAP will support the definition of endotypes, i.e. a<br /><br>more precise disease classification, a definition of biomarkers enabling<br /><br>patient stratification and patient-directed care strategies, and the early<br /><br>identification of the most suitable therapy for every patient. </p><br>
- Secondary Outcome Measures
Name Time Method <p>BIOMAP will also stimulate future research on mechanisms and innovative<br /><br>treatments directed at endotype components. </p><br>